Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051687016> ?p ?o ?g. }
- W2051687016 endingPage "1127" @default.
- W2051687016 startingPage "1120" @default.
- W2051687016 abstract "The effect of folate status on breast cancer resistance protein (BCRP)-mediated drug resistance to epidermal growth factor receptor (EGFR)-targeted drugs, such as gefitinib and erlotinib, was investigated in two human colon cancer cell lines, WiDr and Caco-2, of which the latter displayed greater sensitivity to these drugs due to high EGFR expression. Caco-2 LF/LV cells, growing under low-folate (LF) conditions, showed increased BCRP protein expression compared with the high-folate (HF) counterpart, which was associated with 1.8-fold resistance to gefitinib. Of note, the BCRP-specific inhibitor Ko143 completely reverted this phenotype. WiDr LF cells also showed slightly increased BCRP expression compared with the HF cells, but no differences in gefitinib sensitivity were observed. Both Caco-2 LF/LV and WiDr LF cells showed 2.4- and 2.3-fold resistance to erlotinib, respectively, compared with their HF counterparts, which mechanistically seemed BCRP unrelated, as Ko143 had no effect on erlotinib activity. In conclusion, our data suggest that in EGFR-expressing Caco-2 cells, BCRP is one of the determinants of gefitinib resistance but not of erlotinib resistance. Beyond this, folate depletion can provoke an additional decrease in gefitinib and erlotinib activity by mechanisms dependent or independent of BCRP modulation." @default.
- W2051687016 created "2016-06-24" @default.
- W2051687016 creator A5007946879 @default.
- W2051687016 creator A5022690650 @default.
- W2051687016 creator A5035296183 @default.
- W2051687016 creator A5041229832 @default.
- W2051687016 creator A5079186496 @default.
- W2051687016 creator A5083660823 @default.
- W2051687016 date "2009-03-10" @default.
- W2051687016 modified "2023-10-17" @default.
- W2051687016 title "Impact of cellular folate status and epidermal growth factor receptor expression on BCRP/ABCG2-mediated resistance to gefitinib and erlotinib" @default.
- W2051687016 cites W1981078630 @default.
- W2051687016 cites W1984246155 @default.
- W2051687016 cites W1986944635 @default.
- W2051687016 cites W1988172699 @default.
- W2051687016 cites W1996189033 @default.
- W2051687016 cites W1998418923 @default.
- W2051687016 cites W2011926633 @default.
- W2051687016 cites W2031564220 @default.
- W2051687016 cites W2039633811 @default.
- W2051687016 cites W2050464736 @default.
- W2051687016 cites W2052912120 @default.
- W2051687016 cites W2054814252 @default.
- W2051687016 cites W2055757796 @default.
- W2051687016 cites W2071831214 @default.
- W2051687016 cites W2072517578 @default.
- W2051687016 cites W2082469361 @default.
- W2051687016 cites W2083698338 @default.
- W2051687016 cites W2101697551 @default.
- W2051687016 cites W2104135961 @default.
- W2051687016 cites W2118667947 @default.
- W2051687016 cites W2128654752 @default.
- W2051687016 cites W2129342281 @default.
- W2051687016 cites W2130244550 @default.
- W2051687016 cites W2140744545 @default.
- W2051687016 cites W2141937149 @default.
- W2051687016 cites W2147930289 @default.
- W2051687016 cites W2148467418 @default.
- W2051687016 cites W2151566058 @default.
- W2051687016 cites W2161133634 @default.
- W2051687016 cites W2171223909 @default.
- W2051687016 doi "https://doi.org/10.1038/sj.bjc.6604980" @default.
- W2051687016 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2669988" @default.
- W2051687016 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19277036" @default.
- W2051687016 hasPublicationYear "2009" @default.
- W2051687016 type Work @default.
- W2051687016 sameAs 2051687016 @default.
- W2051687016 citedByCount "34" @default.
- W2051687016 countsByYear W20516870162012 @default.
- W2051687016 countsByYear W20516870162013 @default.
- W2051687016 countsByYear W20516870162014 @default.
- W2051687016 countsByYear W20516870162015 @default.
- W2051687016 countsByYear W20516870162016 @default.
- W2051687016 countsByYear W20516870162017 @default.
- W2051687016 countsByYear W20516870162018 @default.
- W2051687016 countsByYear W20516870162019 @default.
- W2051687016 countsByYear W20516870162022 @default.
- W2051687016 crossrefType "journal-article" @default.
- W2051687016 hasAuthorship W2051687016A5007946879 @default.
- W2051687016 hasAuthorship W2051687016A5022690650 @default.
- W2051687016 hasAuthorship W2051687016A5035296183 @default.
- W2051687016 hasAuthorship W2051687016A5041229832 @default.
- W2051687016 hasAuthorship W2051687016A5079186496 @default.
- W2051687016 hasAuthorship W2051687016A5083660823 @default.
- W2051687016 hasBestOaLocation W20516870161 @default.
- W2051687016 hasConcept C104317684 @default.
- W2051687016 hasConcept C126322002 @default.
- W2051687016 hasConcept C149011108 @default.
- W2051687016 hasConcept C170493617 @default.
- W2051687016 hasConcept C185592680 @default.
- W2051687016 hasConcept C2778087573 @default.
- W2051687016 hasConcept C2779438470 @default.
- W2051687016 hasConcept C2780580887 @default.
- W2051687016 hasConcept C2909325608 @default.
- W2051687016 hasConcept C44312359 @default.
- W2051687016 hasConcept C502942594 @default.
- W2051687016 hasConcept C512196 @default.
- W2051687016 hasConcept C55493867 @default.
- W2051687016 hasConcept C71924100 @default.
- W2051687016 hasConcept C86803240 @default.
- W2051687016 hasConcept C98274493 @default.
- W2051687016 hasConceptScore W2051687016C104317684 @default.
- W2051687016 hasConceptScore W2051687016C126322002 @default.
- W2051687016 hasConceptScore W2051687016C149011108 @default.
- W2051687016 hasConceptScore W2051687016C170493617 @default.
- W2051687016 hasConceptScore W2051687016C185592680 @default.
- W2051687016 hasConceptScore W2051687016C2778087573 @default.
- W2051687016 hasConceptScore W2051687016C2779438470 @default.
- W2051687016 hasConceptScore W2051687016C2780580887 @default.
- W2051687016 hasConceptScore W2051687016C2909325608 @default.
- W2051687016 hasConceptScore W2051687016C44312359 @default.
- W2051687016 hasConceptScore W2051687016C502942594 @default.
- W2051687016 hasConceptScore W2051687016C512196 @default.
- W2051687016 hasConceptScore W2051687016C55493867 @default.
- W2051687016 hasConceptScore W2051687016C71924100 @default.
- W2051687016 hasConceptScore W2051687016C86803240 @default.
- W2051687016 hasConceptScore W2051687016C98274493 @default.
- W2051687016 hasIssue "7" @default.